Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Transtracheal local anaesthetic group: Patients will receive trans-tracheal injection of 5ml of 4% lignocaine
Control Intervention1: Placebo group: control group patients will receive t
Sponsors
Amrita Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18ââ?¬â??60 years, of the American Society of Anaesthesiologists (ASA) physical status 1ââ?¬â??2, undergoing breast cancer surgeries lasting 2-3h under general anaesthesia with laryngeal mask airway
Exclusion criteria
Exclusion criteria: Patients with an anticipated difficult airway, history of allergy to the test drug, who required more than one attempt at insertion and those with pre-operative sore throat or already on analgesics or steroids (systemic or inhaled)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective is to assess the reduction in incidence and severity of postoperative sore throat.Timepoint: Post operative period upto 24 h | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives include reduction in incidence of postoperative hoarseness of voice and cough.Timepoint: Post operative period upto 24 h | — |
Countries
India
Contacts
Public ContactNitu PV
Amrita Institute of medical Sciences
Outcome results
None listed